immune cell – APBN New Site

Biosyngen Pte Ltd Launched Biological Production Base for Commercialisation of Immune Cell Therapeutics in China

February 25, 2022 . Inside Industry . Vol 26 No 2

The facility will enable Biosyngen to develop safe, effective, and affordable cell therapies benefiting patients worldwide. The inauguration ceremony of Biosyngen Pte. Ltd., (“Biosyngen”) joint...

Faster and Cheaper Manufacturing of CAR-T Production

May 7, 2019 . Eye on China

Gracell Biotechnologies developes FasT CAR-T, a breakthrough technology for hematological malignancies. Gracell Biotechnologies, a China-based immune cell gene therapy company has developed a faster...